Author:
Hu Qin,Wang Runtian,Zhang Jiaxin,Xue Qun,Ding Bo
Funder
Science and Technology Project of Nantong City
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference78 articles.
1. Siegel RL, Miller KD, Fuchs HE, et al. (2022)Cancer statistics, CA: a cancer journal for clinicians, 72: 7–33
2. Treatment choices for non-small cell lung cancer, by stage. https://www.cancer.org/cancer/lung-cancer/treating-non-small-cell/by-stage.html
3. Leprieur EG, Dumenil C, Julie C, Giraud V, Dumoulin J, Labrune S, Chinet T (2017) Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges. European J Cancer 78:16–23
4. Zhang J, Veeramachaneni N (2022) Targeting interleukin-1β and inflammation in lung cancer. Biomark Res 10:5
5. Labani-Motlagh A, Ashja-Mahdavi M, Loskog A (2020) The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 11:940
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献